AM580 is a retinoic acid receptor (RAR) agonist that is selective for RARα (EC50 = 0.36 nM) compared to RARβ (EC50 = 24.6 nM) and RARγ (EC50 = 27.9 nM; Bernard et al.) It is a derivative of retinoic acid (RA), however it demonstrates greater specific binding to RARα compared to RA, which exhibits little selectivity across RARα, β, or γ (Gianní et al.; Bernard et al.; Kim et al; Rochette-Egly & Germain)
Promotes reprogramming of somatic cells to induced pluripotent stem cells (Wang et al.)
Induces differentiation of human induced pluripotent stem cells into intermediate mesoderm, in combination with the GSK3β inhibitor CHIR99021 (Araoka et al.)
Inhibits tumor cell proliferation and survival signaling pathways, and induces apoptosis, leading to inhibition of mouse mammary tumor virus (MMTV)-neu- and MMTV-wnt1-induced mammary gland hyperplasia (Lu et al.)
Inhibits tumor growth in MMTV-Myc mice (Bosch et al.)
Inhibits endometrial cancer cell proliferation (Cheng et al.)
Induces differentiation in acute promyelocytic leukemia cells (Gianní et al.)
Technical specifications
Brand
STEMCELL Technologies
B-LABO ref.
BL-RE-151716
CAS
102121-60-8
Synonym
CD336; NSC 608001; Ro 40-6055
Quantity
1 mg
Molecular formula
C22H25NO3
Purity
≥98%
A question or a specific configuration? Contact us for a quote.